Margie has >25 years of US and ex-US success. As Sr Vice President King Pharmaceuticals she led the largest division growing revenues 14% to $1.2B. She held various global and US Leadership positions for SmithKline in Sales, Marketing, Strategy Development, Finance & Admin. As Executive Director for GSK she headed up mergers & acquisitions and grew an orphan product to market leader $40M sales. She also led Merck's $1.5B global stroke franchise.

Dr. Pamplin most recently served as Chief of Medical Affairs King Pharmaceuticals. He is board certified in Internal Medicine with >35 years of research and drug development experience with expertise in Medical Informatics and Information Technology. He held senior positions in Quintiles and in the US Army (Retired Colonel).

Greg most recently served as Sr Director Strategic Product Development for Labopharm. He has >25 years in senior positions with PharmaCense, King, Serono and Andrx and has grown brands in highly competitive markets from $0-$70M with demonstrated expertise in new product launches.

Jack most recently served as Principal, Growth Advisors LLC. He has >25 years experience in senior positions in healthcare Information technology and emerging business market development. Prior to Growth Advisors Jack was a Senior Executive for Shared Medical Systems, now Siemens.

Served as Principal, Vanguard Group. She has > 25 years experience in financial services, including 7 years leading Vanguard's International Business serving European and Americas (ex-US) Institutional Investors.